Cleared Traditional

K020967 - TERUMO KHURI MYOCARDIAL PH MONITORING S...

K020967 is an FDA 510(k) clearance for TERUMO KHURI MYOCARDIAL PH MONITORING S..., manufactured by Terumo Cardiovascular Systems Corp.. The device is a Class 2 Anesthesiology device with product code CBZ cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K020967 · Terumo Cardiovascular Systems Corp. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2002
Decision
87d
Days
Class 2
Risk

K020967 is an FDA 510(k) clearance for the TERUMO KHURI MYOCARDIAL PH MONITORING SYSTEM. Classified as Analyzer, Ion, Hydrogen-ion (ph), Blood-phase, Indwelling (product code CBZ), Class II - Special Controls.

Submitted by Terumo Cardiovascular Systems Corp. (Tistin, US). The FDA issued a Cleared decision on June 20, 2002 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1170 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Terumo Cardiovascular Systems Corp. devices

FDA 510(k) Submission Details - K020967

510(k) Number K020967 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2002
Decision Date June 20, 2002
Days to Decision 87 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 140d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CBZ Device Classification - Class 2, Special Controls

Product Code CBZ Analyzer, Ion, Hydrogen-ion (ph), Blood-phase, Indwelling
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1170
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBZ Analyzer, Ion, Hydrogen-ion (ph), Blood-phase, Indwelling

Devices cleared under the same product code (CBZ) and FDA review panel - the closest regulatory comparables to K020967.
MODEL PB3300 INTRA-ARTER BLOOD GAS MONIT SYS, MODI
K931112 · Puritan Bennett Corp. · Jun 1993
HEMOMETRIX CONTINUOUS BLOOD GAS MONITORING SYSTEM
K920061 · Abbott Laboratories · Mar 1992
CDI(TM) 2000 BLOOD GAS MONITORING SYST, MODIFIED
K912030 · 3M Company · Oct 1991
PB3300 SENSING CATHETER FOR CONTINUOUS MEASUREMENT
K912428 · Puritan Bennett Corp. · Aug 1991
SENSOMAT MUSCLE/TISSUE PH
K803260 · Biochem International, Inc. · Feb 1981
SENSOMAT
K803014 · Biochem International, Inc. · Dec 1980